Methenolone Enanthate 100 is a dihydrotestosterone derived anabolic steroid. EPM 100 contains
methenolone enanthate, a long-acting methenolone ester producing a rapid onset of serum methenolone
with a continued duration of action of 5 to 7 days after IM injection. Methenolone Enanthate 100 is
moderately anabolic with limited androgenic properties. Methenolone cannot aromatize to estrogen,
reducing estrogenic side effects, and has a favorable safety profile among anabolic agents.
As an alternate or adjunctive therapy in patients for the promotion of weight gain following weight loss
and/or muscular atrophy associated with extensive surgery, chronic infections, long term hospitalization, or
severe trauma. To compensate for protein catabolism consequent to corticosteroid therapy.
Male: Gynecomastia, increased frequency of erections, azospermia, priapism, oligospermia, prostatic
hypertrophy,increased risk of prostate carcinoma.
Skin and Appendages: Hirsutism, pattern baldness and acne, gynecomastia.
Fluid/Electrolyte Disturbances: Retention of sodium, chloride, water, potassium, calcium, and inorganic
Gastrointestinal: Nausea, cholestatic jaundice, alterations in liver function tests; rarely, hepatocellular
neoplasms, peliosis hepatitis, hepatic adenomas, and cholestatic hepatitis.
Hematologic: Suppression of clotting factors II, V, VII, & X; bleeding in patients on anti-coagulant therapy.
Nervous System: Increased or decreased libido, headache, anxiety, depression, and generalized paresthesia.
Metabolic: Reduced glucose tolerance and inhibition of gonadotrophin secretion.
Other: Serum lipid changes, hypercalcaemia, hypertension, oedema, and potentiation of sleep apnea.
Adult male: 100 – 200mg injected IM every 3 – 5 days for a duration of 8 to 12 weeks.